Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio Essence (BIOE) Equity Average (2020 - 2025)

Bio Essence has reported Equity Average over the past 6 years, most recently at -$2.6 million for Q4 2025.

  • Quarterly results put Equity Average at -$2.6 million for Q4 2025, up 12.45% from a year ago — trailing twelve months through Dec 2025 was -$2.6 million (up 12.45% YoY), and the annual figure for FY2025 was -$2.5 million, down 8.91%.
  • Equity Average for Q4 2025 was -$2.6 million at Bio Essence, up from -$3.1 million in the prior quarter.
  • Over the last five years, Equity Average for BIOE hit a ceiling of -$1.3 million in Q3 2023 and a floor of -$3.3 million in Q1 2023.
  • Median Equity Average over the past 5 years was -$2.5 million (2021), compared with a mean of -$2.4 million.
  • Biggest five-year swings in Equity Average: soared 55.25% in 2023 and later tumbled 92.8% in 2025.
  • Bio Essence's Equity Average stood at -$2.4 million in 2021, then plummeted by 31.4% to -$3.1 million in 2022, then soared by 50.08% to -$1.6 million in 2023, then tumbled by 89.02% to -$3.0 million in 2024, then rose by 12.45% to -$2.6 million in 2025.
  • The last three reported values for Equity Average were -$2.6 million (Q4 2025), -$3.1 million (Q3 2025), and -$3.1 million (Q2 2025) per Business Quant data.